Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.53 +0.01 (0.40%)
Previous Close $2.52    52 Week High $4.76 
Open $2.59    52 Week Low $1.46 
Day High $2.61    P/E N/A 
Day Low $2.48    EPS $-1.91 
Volume 4,186,789       

(NASDAQ: LEGN) Delayed: 17.61 +0.03 (0.17%)
Previous Close $17.58    52 Week High
Open $17.71    52 Week Low
Day High $17.88    P/E N/A 
Day Low $17.22    EPS
Volume 2,935,696